An efficient, non-viral dendritic vector for gene delivery in tissue engineering.

Area of Science:

• Biomaterials Science
• Gene Therapy
• Tissue Engineering
• Cell Biology

Background:

• Tissue engineering (TE) increasingly integrates gene therapeutics with biomaterial scaffolds.
• Mesenchymal stem cells (MSCs) are crucial for regenerative medicine applications.
• Efficient and safe gene delivery vectors are essential for TE success.

Purpose of the Study:

• To evaluate activated polyamidoamine dendrimer (dPAMAM) as a gene delivery vector for MSCs.
• To assess dPAMAM's efficacy in both monolayer and 3D collagen-based scaffold cultures.
• To compare dPAMAM with polyethylenimine (PEI) for gene delivery in TE.

Main Methods:

• dPAMAM-pDNA and PEI-pDNA polyplexes were formulated at specific mass ratios.
• Gene delivery was tested on MSCs in monolayer culture.
• Polyplexes were soak-loaded onto various collagen-based scaffolds (collagen alone, collagen-CS, collagen-hydroxyapatite, collagen-nanohydroxyapatite, collagen-hyaluronic acid) for 3D culture.

Main Results:

• dPAMAM-pDNA polyplexes facilitated prolonged reporter gene expression in monolayer MSCs, outperforming PEI-pDNA polyplexes.
• Soak-loaded dPAMAM-pDNA polyplexes on collagen-chondroitin sulphate (CS) scaffolds resulted in superior transgene expression compared to PEI-pDNA.
• Transgene expression varied significantly across different collagen composite scaffolds, indicating scaffold-dependent delivery.

Conclusions:

• dPAMAM serves as a biocompatible and effective gene delivery vector for TE applications.
• The dPAMAM vector's performance can be optimized by matching it with specific composite scaffold types.
• This tailored approach holds promise for regenerating diverse tissue defects.